EYE 5.56% 19.0¢ nova eye medical limited

That ends up being a bit over $1 billion AUD upfront and another...

  1. 16,649 Posts.
    lightbulb Created with Sketch. 4505
    That ends up being a bit over $1 billion AUD upfront and another billion in contingent payments. 2RT is up to the final pivotal trial which is what they are seeking the partnership for, meaning they are ahead of that drug. In fact 2RT is even ready for immediate commercialisation in Europe upon securing a deal. Something tells me this partnership deal coming for 2RT will surprise many investors
 
watchlist Created with Sketch. Add EYE (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.